International Journal of Cancer Management

Published by: Kowsar

Gliosarcoma Protein - Protein Interaction Network Analysis and Gene Ontology

Mostafa Rezaei Tavirani 1 , * , Vahid Mansouri 1 , Sina Rezaei Tavirani 1 , Saeed Hesami Tackallou 2 and Mohammad Rostami - Nejad 3
Authors Information
1 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Islamic Azad University, Central Tehran Branch, Tehran, Iran
3 Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: May 2018, 11 (5); e65701
  • Published Online: May 14, 2018
  • Article Type: Research Article
  • Received: December 30, 2017
  • Revised: January 22, 2018
  • Accepted: March 6, 2018
  • DOI: 10.5812/ijcm.65701

To Cite: Rezaei Tavirani M, Mansouri V, Rezaei Tavirani S, Hesami Tackallou S, Rostami - Nejad M. Gliosarcoma Protein - Protein Interaction Network Analysis and Gene Ontology, Int J Cancer Manag. 2018 ; 11(5):e65701. doi: 10.5812/ijcm.65701.

Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Singh G, Das KK, Sharma P, Guruprasad B, Jaiswal S, Mehrotra A, et al. Cerebral gliosarcoma: Analysis of 16 patients and review of literature. Asian J Neurosurg. 2015;10(3):195-202. doi: 10.4103/1793-5482.161173. [PubMed: 26396606]. [PubMed Central: PMC4553731].
  • 2. Pardo J, Murcia M, Garcia F, Alvarado A. Gliosarcoma: A rare primary CNS tumor. Presentation of two cases. Rep Pract Oncol Radiother. 2010;15(4):98-102. doi: 10.1016/j.rpor.2010.05.003. [PubMed: 24376932]. [PubMed Central: PMC3863303].
  • 3. Little JA, Shanoff HM, Roe RD, Csima A, Yano R. Studies of Male Survivors of Myocardial Infarction. Iv. Serum Lipids and Five-Year Survival. Circulation. 1965;31:854-62. [PubMed: 14297519].
  • 4. Hattab EM, Harris BT. Molecular Pathology of the Central Nervous System. Molecular Genetic Pathology. Springer; 2008. p. 497-532.
  • 5. Newton HB, Otero JJ. Overview of epidemiology, pathology, and treatment of primary brain tumors. Epilepsy and Brain Tumors. Elsevier; 2015. p. 11-28.
  • 6. Cho SY, Park C, Na D, Han JY, Lee J, Park OK, et al. High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients. Exp Mol Med. 2017;49(4). e317. doi: 10.1038/emm.2017.9. [PubMed: 28408749]. [PubMed Central: PMC5420801].
  • 7. Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129(6):829-48. doi: 10.1007/s00401-015-1432-1. [PubMed: 25943888].
  • 8. Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, et al. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol. 2016;11(1):55. doi: 10.1186/s13000-016-0506-2. [PubMed: 27350555]. [PubMed Central: PMC4924254].
  • 9. Nsir AB, Thai Q-A, Kassar AZ, Said IB, Jemel H. Primary cerebellar gliosarcoma with extracranial metastases: an orphan differential diagnosis. World Neurosurg. 2015;84(6):2076. e13-7.
  • 10. Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H. Genetic profile of gliosarcomas. Am J Pathol. 2000;156(2):425-32. doi: 10.1016/S0002-9440(10)64746-3. [PubMed: 10666371]. [PubMed Central: PMC1850048].
  • 11. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000;24(3):227-35. doi: 10.1038/73432. [PubMed: 10700174].
  • 12. deCarvalho AC, Nelson K, Lemke N, Lehman NL, Arbab AS, Kalkanis S, et al. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells. 2010;28(2):181-90. doi: 10.1002/stem.264. [PubMed: 19937755]. [PubMed Central: PMC2873790].
  • 13. Miller CR, Perry A. Glioblastoma. Arch Pathol Lab Med. 2007;131(3):397-406. doi: 10.1043/1543-2165(2007)131[397:G]2.0.CO;2. [PubMed: 17516742].
  • 14. Safari-Alighiarloo N, Taghizadeh M, Rezaei-Tavirani M, Goliaei B, Peyvandi AA. Protein-protein interaction networks (PPI) and complex diseases. Gastroenterol Hepatol Bed Bench. 2014;7(1):17-31. [PubMed: 25436094]. [PubMed Central: PMC4017556].
  • 15. Karbalaei R, Piran M, Rezaei-Tavirani M, Asadzadeh-Aghdaei H, Heidari MH. A systems biology analysis protein-protein interaction of NASH and IBD based on comprehensive gene information. Gastroenterol Hepatol Bed Bench. 2017;10(3):194-201. [PubMed: 29118935]. [PubMed Central: PMC5660269].
  • 16. Zali H, Rezaei Tavirani M. Meningioma protein-protein interaction network. Arch Iran Med. 2014;17(4):262-72. [PubMed: 24724603].
  • 17. Safari-Alighiarloo N, Rezaei-Tavirani M, Taghizadeh M, Tabatabaei SM, Namaki S. Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ. 2016;4. e2775. doi: 10.7717/peerj.2775. [PubMed: 28028462]. [PubMed Central: PMC5183126].
  • 18. Peyvandi AA, Khoshsirat S, Safaei A, Rezaei-Tavirani M, Azodi-Zamanian M. Interactome Analysis of 11-Dehydrosinulariolide-Treated Oral Carcinoma Cell Lines Such as Ca9-22 and CAL-27 and Melanoma Cell Line. Int J Canc Manag. 2017;10(7). doi: 10.5812/ijcm.10096.
  • 19. Yildirim MA, Goh KI, Cusick ME, Barabasi AL, Vidal M. Drug-target network. Nat Biotechnol. 2007;25(10):1119-26. doi: 10.1038/nbt1338. [PubMed: 17921997].
  • 20. Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R. Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol. 2010;6(1). e1000641. doi: 10.1371/journal.pcbi.1000641. [PubMed: 20090828]. [PubMed Central: PMC2797085].
  • 21. Abbaszadeh HA, Peyvandi AA, Sadeghi Y, Safaei A, Zamanian-Azodi M, Khoramgah MS, et al. Er:YAG Laser and Cyclosporin A Effect on Cell Cycle Regulation of Human Gingival Fibroblast Cells. J Lasers Med Sci. 2017;8(3):143-9. doi: 10.15171/jlms.2017.26. [PubMed: 29123635]. [PubMed Central: PMC5662504].
  • 22. Rezaei-Tavirani M, Rezaei-Tavirani M, Mansouri V, Mahdavi SM, Valizadeh R, Rostami-Nejad M, et al. Introducing crucial protein panel of gastric adenocarcinoma disease. Gastroenterol Hepatol Bed Bench. 2017;10(1):21-8. [PubMed: 28331560]. [PubMed Central: PMC5346820].
  • 23. Safaei A, Rezaei Tavirani M, Zamanian Azodi M, Lashay A, Mohammadi SF, Ghasemi Broumand M, et al. Diabetic Retinopathy and Laser Therapy in Rats: A Protein-Protein Interaction Network Analysis. J Lasers Med Sci. 2017;8(Suppl 1):S20-1. doi: 10.15171/jlms.2017.s4. [PubMed: 29071030]. [PubMed Central: PMC5642173].
  • 24. Manzoni C, Ferrari R, Kia D, Lovering RC, Hardy J, Lewis PA. Protein Network Analysis to Prioritize Candidate Genes and Pathways for Sporadic Disease: A Comparison between Frontotemporal Dementia and Parkinson’s Disease. Alzheimer's & Dementia. 2017;13(7):P555. doi: 10.1016/j.jalz.2017.07.156.
  • 25. Rezaei Tavirani M, Ok HF, Zamanian Azodi M, Rezaei Tavirani M. Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping. Iran J Child Neurol. 2017;11(4):7-14. [PubMed: 29201118]. [PubMed Central: PMC5703623].
  • 26. Khayer N, Zamanian-Azodi M, Mansouri V, Ghassemi-Broumand M, Rezaei-Tavirani M, Heidari MH, et al. Oral squamous cell cancer protein-protein interaction network interpretation in comparison to esophageal adenocarcinoma. Gastroenterol Hepatol Bed Bench. 2017;10(2):118-24. [PubMed: 28744358]. [PubMed Central: PMC5495899].
  • 27. Rezaei-Tavirani M, Zamanian-Azodi M, Rajabi S, Masoudi-Nejad A, Rostami-Nejad M, Rahmatirad S. Protein Clustering and Interactome Analysis in Parkinson and Alzheimer's Diseases. Arch Iran Med. 2016;19(2):101-9. [PubMed: 26838080].
  • 28. Zamanian-Azodi M, Rezaei-Tavirani M, Rahmati-Rad S, Hasanzadeh H, Rezaei Tavirani M, Seyyedi SS. Protein-Protein Interaction Network could reveal the relationship between the breast and colon cancer. Gastroenterol Hepatol Bed Bench. 2015;8(3):215-24. [PubMed: 26328044]. [PubMed Central: PMC4553162].
  • 29. Huttner A. Overview of primary brain tumors: pathologic classification, epidemiology, molecular biology, and prognostic markers. Hematol Oncol Clin North Am. 2012;26(4):715-32. doi: 10.1016/j.hoc.2012.05.004. [PubMed: 22794280].
  • 30. Warnick RE, Pietronigro DD, McBride DQ, Flamm ES. In vivo metabolism of radiolabeled putrescine in gliomas: implications for positron emission tomography of brain tumors. Neurosurgery. 1988;23(4):464-9. [PubMed: 3264387].
  • 31. Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst. 2006;22(3):314-9. doi: 10.1007/s00381-005-1239-9. [PubMed: 16133270].
  • 32. Machuca TN, Prevedello DM, Pope LZ, Haratz SS, Araujo JC, Torres LF. Gliosarcoma: report of four cases with immunohistochemical findings. Arq Neuropsiquiatr. 2004;62(3A):608-12. [PubMed: 15334217].
  • 33. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, et al. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol. 2009;27(4):579-84. doi: 10.1200/JCO.2008.18.9639. [PubMed: 19075262]. [PubMed Central: PMC2645859].
  • 34. Knobbe CB, Reifenberger G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol. 2003;13(4):507-18. [PubMed: 14655756].
  • 35. Kleihues P, Ohgaki H. Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol Pathol. 2000;28(1):164-70. doi: 10.1177/019262330002800121. [PubMed: 10669004].
  • 36. Duclot F, Kabbaj M. The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders. Front Behav Neurosci. 2017;11:35. doi: 10.3389/fnbeh.2017.00035. [PubMed: 28321184]. [PubMed Central: PMC5337695].
  • 37. Dieterich LC, Mellberg S, Langenkamp E, Zhang L, Zieba A, Salomaki H, et al. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFbeta2 in vascular abnormalization. J Pathol. 2012;228(3):378-90. doi: 10.1002/path.4072. [PubMed: 22786655].
  • 38. Coskunpinar E, Akkaya N, Yildiz P, Oltulu YM, Aynaci E, Isbir T, et al. The significance of HSP90AA1, HSP90AB1 and HSP90B1 gene polymorphisms in a Turkish population with non-small cell lung cancer. Anticancer Res. 2014;34(2):753-7. [PubMed: 24511009].
  • 39. Chu SH, Liu YW, Zhang L, Liu B, Li L, Shi JZ, et al. Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells. Mol Biol Rep. 2013;40(1):1-6. doi: 10.1007/s11033-012-1930-3. [PubMed: 23135731].
  • 40. Gorska M, Marino Gammazza A, Zmijewski MA, Campanella C, Cappello F, Wasiewicz T, et al. Geldanamycin-induced osteosarcoma cell death is associated with hyperacetylation and loss of mitochondrial pool of heat shock protein 60 (hsp60). PLoS One. 2013;8(8). e71135. doi: 10.1371/journal.pone.0071135. [PubMed: 24015183]. [PubMed Central: PMC3756027].
  • 41. Tjuvajev J, Gansbacher B, Desai R, Beattie B, Kaplitt M, Matei C, et al. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma. Cancer Res. 1995;55(9):1902-10. [PubMed: 7728757].
  • 42. Li F, Chen DN, He CW, Zhou Y, Olkkonen VM, He N, et al. Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). J Proteomics. 2012;77:225-36. doi: 10.1016/j.jprot.2012.09.002. [PubMed: 22986152].
  • 43. Fan L-Q, Li Y, Chen M-L, Zhao Q, Tan B-B, Wang D, et al. AB27. Proteomics research about effect of ZNF139 knockdown with RNA interference on serum of orthotopic transplantation nude mouse with gastric cancer. Translational Gastrointestinal Cancer. 2013.
  • 44. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res. 2000;60(2):417-24. [PubMed: 10667596].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments